Paramita M Ghosh

InstitutionUniversity of California Davis
Address4860 Y Street Suite 3500
CA 95817
vCardDownload vCard

    Collapse Research 
    Collapse Research Activities and Funding
    (PQD-1) Selective pressure of antiandrogens on castration resistant prostate canc
    NIH/NCI R01CA185509Jul 18, 2014 - May 31, 2018
    Role: Principal Investigator
    Loss of Filamin A Nuclear Localization in Prostate Cancer Progression
    VA I01BX000400Apr 1, 2009 - Jun 30, 2019
    Role: Principal Investigator
    Rapamycin Regulation of the Androgen Receptor: Implications in Prostate Cancer
    NIH/NCI R01CA133209Mar 13, 2009 - Dec 31, 2014
    Role: Principal Investigator
    Role of HER3 in androgen-independent prostate cancer
    NIH/NCI R21CA109057Sep 7, 2005 - Aug 31, 2008
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. D'Abronzo LS, Ghosh PM. eIF4E Phosphorylation in Prostate Cancer. Neoplasia. 2018 May 03; 20(6):563-573. PMID: 29730477.
      View in: PubMed
    2. D'Abronzo LS, Pan CX, Ghosh PM. Evaluation of Protein Levels of the Receptor Tyrosine Kinase ErbB3 in Serum. Methods Mol Biol. 2018; 1655:319-334. PMID: 28889394.
      View in: PubMed
    3. Kiss Z, Ghosh PM. WOMEN IN CANCER THEMATIC REVIEW: Circadian rhythmicity and the influence of 'clock' genes on prostate cancer. Endocr Relat Cancer. 2016 11; 23(11):T123-T134. PMID: 27660402.
      View in: PubMed
    4. Ghosh PM. WOMEN IN CANCER PROFILE: From physics to cancer biology and everywhere in between. Endocr Relat Cancer. 2016 11; 23(11):P15-P21. PMID: 27605444.
      View in: PubMed
    5. Pan CX, Zhang H, Tepper CG, Lin TY, Davis RR, Keck J, Ghosh PM, Gill P, Airhart S, Bult C, Gandara DR, Liu E, de Vere White RW. Development and Characterization of Bladder Cancer Patient-Derived Xenografts for Molecularly Guided Targeted Therapy. PLoS One. 2015; 10(8):e0134346. PMID: 26270481; PMCID: PMC4535951.
    6. Narayanan KB, Ali M, Barclay BJ, Cheng QS, D'Abronzo L, Dornetshuber-Fleiss R, Ghosh PM, Gonzalez Guzman MJ, Lee TJ, Leung PS, Li L, Luanpitpong S, Ratovitski E, Rojanasakul Y, Romano MF, Romano S, Sinha RK, Yedjou C, Al-Mulla F, Al-Temaimi R, Amedei A, Brown DG, Ryan EP, Colacci A, Hamid RA, Mondello C, Raju J, Salem HK, Woodrick J, Scovassi AI, Singh N, Vaccari M, Roy R, Forte S, Memeo L, Kim SY, Bisson WH, Lowe L, Park HH. Disruptive environmental chemicals and cellular mechanisms that confer resistance to cell death. Carcinogenesis. 2015 Jun; 36 Suppl 1:S89-110. PMID: 26106145; PMCID: PMC4565614.
    7. Savoy RM, Chen L, Siddiqui S, Melgoza FU, Durbin-Johnson B, Drake C, Jathal MK, Bose S, Steele TM, Mooso BA, D'Abronzo LS, Fry WH, Carraway KL, Mudryj M, Ghosh PM. Transcription of Nrdp1 by the androgen receptor is regulated by nuclear filamin A in prostate cancer. Endocr Relat Cancer. 2015 Jun; 22(3):369-86. PMID: 25759396; PMCID: PMC4433410.
    8. Ghosh PM, Gao AC. Zoledronic acid at the time of castration prevented castration-induced bone metastasis in mice. Endocr Relat Cancer. 2014 Oct; 21(5):C11-4. PMID: 25183429.
      View in: PubMed
    9. Mooso BA, Vinall RL, Mudryj M, Yap SA, deVere White RW, Ghosh PM. The role of EGFR family inhibitors in muscle invasive bladder cancer: a review of clinical data and molecular evidence. J Urol. 2015 Jan; 193(1):19-29. PMID: 25158272; PMCID: PMC4405894.
    10. Savoy RM, Ghosh PM. The dual role of filamin A in cancer: can't live with (too much of) it, can't live without it. Endocr Relat Cancer. 2013 Dec; 20(6):R341-56. PMID: 24108109; PMCID: PMC4376317.
    11. Savoy RM, Ghosh PM. The changing roles of steroid nuclear receptors with prostate cancer progression. Endocr Relat Cancer. 2013 Aug; 20(4):C9-11. PMID: 23744763.
      View in: PubMed
    12. Savoy RM, Ghosh PM. Linking inflammation and neuroendocrine differentiation: the role of macrophage migration inhibitory factor-mediated signaling in prostate cancer. Endocr Relat Cancer. 2013 Jun; 20(3):C1-4. PMID: 23612613.
      View in: PubMed
    13. Mooso BA, Vinall RL, Tepper CG, Savoy RM, Cheung JP, Singh S, Siddiqui S, Wang Y, Bedolla RG, Martinez A, Mudryj M, Kung HJ, Devere White RW, Ghosh PM. Enhancing the effectiveness of androgen deprivation in prostate cancer by inducing Filamin A nuclear localization. Endocr Relat Cancer. 2012 Dec; 19(6):759-77. PMID: 22993077; PMCID: PMC3540117.
    14. Chen L, Mooso BA, Jathal MK, Madhav A, Johnson SD, van Spyk E, Mikhailova M, Zierenberg-Ripoll A, Xue L, Vinall RL, deVere White RW, Ghosh PM. Dual EGFR/HER2 inhibition sensitizes prostate cancer cells to androgen withdrawal by suppressing ErbB3. Clin Cancer Res. 2011 Oct 01; 17(19):6218-28. PMID: 21844010; PMCID: PMC3186857.
    15. Mooso B, Madhav A, Johnson S, Roy M, Moore ME, Moy C, Loredo GA, Mehta RG, Vaughan AT, Ghosh PM. Androgen Receptor regulation of Vitamin D receptor in response of castration-resistant prostate cancer cells to 1a-Hydroxyvitamin D5 - a calcitriol analog. Genes Cancer. 2010 Nov 16; 1(9):927-940. PMID: 21552398.
      View in: PubMed
    16. Chen H, Libertini SJ, George M, Dandekar S, Tepper CG, Al-Bataina B, Kung HJ, Ghosh PM, Mudryj M. Genome-wide analysis of androgen receptor binding and gene regulation in two CWR22-derived prostate cancer cell lines. Endocr Relat Cancer. 2010 Dec; 17(4):857-73. PMID: 20634343; PMCID: PMC3539310.
    17. Chen L, Siddiqui S, Bose S, Mooso B, Asuncion A, Bedolla RG, Vinall R, Tepper CG, Gandour-Edwards R, Shi X, Lu XH, Siddiqui J, Chinnaiyan AM, Mehra R, Devere White RW, Carraway KL, Ghosh PM. Nrdp1-mediated regulation of ErbB3 expression by the androgen receptor in androgen-dependent but not castrate-resistant prostate cancer cells. Cancer Res. 2010 Jul 15; 70(14):5994-6003. PMID: 20587519; PMCID: PMC2905475.
    18. Ghosh PM, Malik SN, Bedolla RG, Wang Y, Mikhailova M, Prihoda TJ, Troyer DA, Kreisberg JI. Signal transduction pathways in androgen-dependent and -independent prostate cancer cell proliferation. Endocr Relat Cancer. 2005 Mar; 12(1):119-34. PMID: 15788644.
      View in: PubMed